TOTAL COMPLEMENT ACTIVITY DECREASED

This adverse event was reported 61 times

These drugs are most commonly taken by patients reporting TOTAL COMPLEMENT ACTIVITY DECREASED:

# Drug Count
0 ECULIZUMAB 49
1 FOLIC ACID 9
2 RITUXIMAB 9
3 RAVULIZUMAB 8
4 PREDNISONE 6
5 ASPIRIN 5
6 ASPIRIN 325 MG 5
7 ASPIRIN 81 MG 5
8 HYDROXYCHLOROQUINE 5
9 ACETAMINOPHEN 4
See all common drugs associated with TOTAL COMPLEMENT ACTIVITY DECREASED

TOTAL COMPLEMENT ACTIVITY DECREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ECULIZUMAB 49 0.0009
1 ERGOCALCIFEROL 3 0.0001
2 SODIUM BICARBONATE INJECTION, 2 0.0001
3 EPOETIN ALFA 1 0.0001
4 ACETAMINOPHEN AND CODEINE 1 0.0001
5 LABETALOL 1 0.0001
6 MUPIROCIN CALCIUM 1 0.0001
7 TELMISARTAN 1 0.0001
8 CALCITRIOL CAPSULES 0.25 MCG 1 0.0000
9 CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE 1 0.0000
See all drugs enriched for association with TOTAL COMPLEMENT ACTIVITY DECREASED

TOTAL COMPLEMENT ACTIVITY DECREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Complement Inhibitor [EPC] 53 0.0009
1 Provitamin D2 Compound [EPC] 3 0.0001
2 RNA Synthetase Inhibitor Antibacterial [EPC] 1 0.0001
3 Vitamin D3 Analog [EPC] 1 0.0000
4 Iron Chelator [EPC] 1 0.0000
5 Oxazolidinone Antibacterial [EPC] 1 0.0000
6 Vitamin D [EPC] 9 0.0000
7 Penem Antibacterial [EPC] 1 0.0000
8 CD20-directed Cytolytic Antibody [EPC] 9 0.0000
9 Vitamin B12 [EPC] 9 0.0000
See all drug classes enriched for association with TOTAL COMPLEMENT ACTIVITY DECREASED